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Introduction {#sec001}
============

Astrocytes constitute a major subset of glial cells that carry out a wide variety of critical operations in the mammalian brain. It is well-established that astrocytes play a supportive role for neurons by providing metabolic support, releasing and taking up neurotransmitters, and maintaining extracellular ionic concentrations. Emerging studies suggest that in addition to the long-established structural role astrocytes play in the maintenance of the blood-brain barrier (BBB), astrocytes are key players in neuronal signaling, brain repair, and immune responses \[[@pone.0117966.ref001]\]. In response to infection, astrocytes release cytokines and chemokines to modulate effector cells. There is also evidence that infection can alter astrocyte function; for example, HIV-infected astrocytes develop abnormal end-feet connections that lead to perturbations in the BBB \[[@pone.0117966.ref002]\]. Other intracellular microbes capable of infecting astrocytes include *Listeria monocytogenes* and *Toxoplasma gondii* \[[@pone.0117966.ref003]--[@pone.0117966.ref005]\], but how they may modulate astrocyte function has yet to be defined.

*T*. *gondii* is an obligate, intracellular parasite belonging to the phylum Apicomplexa, which also includes other notorious protozoan pathogens such as *Plasmodium spp*. (malaria) and *Cryptosporidium spp*. (cryptosporidiosis). Up to a third of the world's population is infected with *T*. *gondii*, which can reactivate as life-threatening disease in immunocompromised individuals. In addition, *T*. *gondii* infection during pregnancy can cause congenital birth defects, including blindness or hydrocephalus \[[@pone.0117966.ref006]\]. *T*. *gondii* is commonly transmitted to virtually any warm-blooded vertebrate through oocysts expelled by its definitive host (felines) or bradyzoite-containing tissue cysts residing in undercooked meat \[[@pone.0117966.ref007]\]. The tachyzoite stage of the parasite's life cycle is characterized by rapid proliferation (doubling time of 6--10 hours) in any nucleated cell and can cause acute disease associated with tissue destruction. In immune competent hosts, the tachyzoites are induced to differentiate into bradyzoites, which are believed to be largely quiescent for the remainder of the host's life \[[@pone.0117966.ref008]\]. Attenuation of host immunity can lead to chronic reactivated infection mentioned above.

*T*. *gondii* can traverse the BBB and activate astrocytes as early as 10 days post-infection \[[@pone.0117966.ref009]\]. While tissue cysts are predominantly seen in neurons during chronic infection, they also occur in microglia and astrocytes during earlier stages of infection \[[@pone.0117966.ref010]\]. Astrocytes execute several immune functions that are involved in the intracerebral immune response to *T*. *gondii*. With microglia and cerebral microvascular endothelial cells, astrocytes form the IFNγ effector cell population that helps control tachyzoite replication in the brain. IFNγ-activated astrocytes significantly inhibit the growth of tachyzoites in mice via an Immunity-Related GTPase (IRG)-mediated mechanism \[[@pone.0117966.ref011],[@pone.0117966.ref012]\] and by expressing pro-inflammatory agents \[[@pone.0117966.ref013]--[@pone.0117966.ref015]\].

To better understand host-parasite interactions, transcriptional profiling and proteomics analyses have been carried out on *T*. *gondii*-infected versus uninfected cells. *T*. *gondii* infection clearly modulates the host cell, resulting in dramatic changes in host gene expression \[[@pone.0117966.ref016]--[@pone.0117966.ref018]\] and protein levels \[[@pone.0117966.ref019],[@pone.0117966.ref020]\]. Data from Saeij *et al*. reveals that message levels for several lysine acetyltransferases (KATs) and lysine deacetylases (KDACs) are significantly increased (HDAC2 and HAT1) or decreased (SIRT5 and MYST4/MORF) in infected cells \[[@pone.0117966.ref017]\]. Modulation of KATs and/or KDACs by intracellular pathogens could impact the host cell transcriptome through histone (de)acetylation, thereby modifying the host cell milieu to favor progression of the parasite's life cycle.

The alteration of host KATs and KDACs is also likely to alter the acetylation status of non-histone proteins as well; we and others have recently found that lysine acetylation is an abundant post-translational modification (PTM) that occurs on thousands of proteins of diverse function throughout multiple cellular compartments \[[@pone.0117966.ref021]\]. So-called "acetylomes" have now been mapped for several organisms, including bacteria \[[@pone.0117966.ref022],[@pone.0117966.ref023]\], plants \[[@pone.0117966.ref024],[@pone.0117966.ref025]\], *Saccharomyces cerevisiae* \[[@pone.0117966.ref026]\] *Drosophila melanogaster* \[[@pone.0117966.ref027]\], human cells \[[@pone.0117966.ref028],[@pone.0117966.ref029]\], and the protozoan parasites *T*. *gondii* and *Plasmodium falciparum* \[[@pone.0117966.ref030]--[@pone.0117966.ref032]\]. In this study, we present the first proteome-wide analysis of lysine acetylation in cortical astrocytes. We also determined the acetylome of *T*. *gondii*-infected astrocytes, which contained differences relative to the acetylated proteins found in uninfected astrocytes. Our findings add a new layer of complexity to the mechanisms intracellular pathogens may employ to manipulate their host. These studies provide a foundation for follow-up investigations aimed at determining the role of lysine acetylation on individual target proteins and how this impacts astrocytic function as well as *T*. *gondii* pathogenesis.

Materials and Methods {#sec002}
=====================

Astrocyte cultures {#sec003}
------------------

Astrocytes were cultured as previously described \[[@pone.0117966.ref033]\]. In brief, cortices from postnatal day 1--2 Sprague-Dawley rat pups were enzymatically digested and triturated. Cortical cells were then resuspended in growth media (Dulbecco's modified Eagle medium (DMEM) containing 5% NuSerum, penicillin 10 units/mL, streptomycin (10μg/ml), L-glutamax (2mM) and B-27) at a density of 2.5 million cells/mL, and resuspended onto 100 μg/ml poly-D-lysine (PDL) coated 10cm dishes. Cells were maintained in humidified incubators at 37°C under 5% CO~2~. Cells were fed every 2--4 days and when the cultures became confluent (7--8 days *in vitro* (DIV)), plates were shaken to remove oligodendrocytes and microglia. After a brief wash, trypsin was used to passage the astrocytes, which were subsequently split onto PDL-coated 10cm dishes (for proteomics or western blotting) or glass coverslips (for immunofluorescence). Similar to previously published findings \[[@pone.0117966.ref033]\], cultures are negative for MAP-2 (neuronal marker), OX-42 (microglial marker), Olig-2 (oligodendrocyte marker) and GFAP positive (\>98%, astrocyte marker).

*T*. *gondii* culture and astrocyte infection {#sec004}
---------------------------------------------

*T*. *gondii* were maintained in human foreskin fibroblasts (HFF; (ATCC CRL-1634)) using DMEM supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen). RH strain tachyzoites cultured in HFFs were then physically separated from host cells by passage through a 23G syringe needle and purified from host cell debris using a 3.0 μm filter \[[@pone.0117966.ref034]\]. Following centrifugation, parasites were resuspended in astrocyte growth medium (see above) and used to infect astrocyte monolayers at a multiplicity of infection (MOI) of 10 for 10 h. Several independent preparations had to be pooled in order to obtain 15 mg of protein lysate necessary to generate the astrocyte acetylomes.

Immunoaffinity enrichment of lysine-acetylated peptides {#sec005}
-------------------------------------------------------

Harvested astrocytes were washed in PBS and resuspended in urea lysis buffer (9.0 M urea, 20 mM HEPES pH 8.0, 2.5 mM sodium pyrophosphate, 1 mM β-glycerol phosphate, 1 mM sodium orthovanadate) freshly supplemented with 10 mM sodium butyrate, a lysine deacetylase (KDAC) inhibitor. Sonicated lysates were centrifuged for 15 min at 4°C at 20,000 x g. Supernatants were collected and reduced with 4.5 mM DTT for 30 min at 55°C, followed by alkylation with iodoacetimide and dilution with 20 mM HEPES, pH 8.0 to normalize protein concentration across all samples. After digestion with 10 μg/mL trypsin-TPCK in 1.0 mM HCl, peptide lysates were acidified with 1% TFA and peptides were desalted over SEP PAK Classic C18 columns (Waters). Peptides were eluted with 40% acetonitrile in 0.1% TFA, dried under vacuum, and stored at-80°C.

Acetylated peptides were enriched using a pan-specific anti-acetyl-lysine antibody (CST \#9895, Cell Signaling Technology) bound to 50 mL packed protein A agarose beads (Roche). Lyophilized peptides were resuspended in MOPS (morpholinepropane sulfonic acid) IAP buffer (50 mM MOPS (pH 7.2), 10 mM KH~2~PO~4~, 50 mM NaCl) and centrifuged for 5 min at 12,000 rpm. Supernatants were mixed with anti-acetyl-lysine beads for 2.5 h at 4°C and then centrifuged for 30 s at 5,400 rpm at 4°C. Beads were washed in MOPS IAP buffer, then in water, prior to elution of the peptides with 0.15% TFA. In preparation for analysis, the peptides were desalted over Empore C~18~ tips (Sigma) and eluted with 60% acetonitrile in 0.1% TFA.

LC-MS/MS analysis {#sec006}
-----------------

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed at Cell Signaling Technology (Danvers, MA). Peptides were loaded directly onto a 10 cm x 75 μm PicoFrit capillary column packed with Magic C~18~ AQ reversed-phase resin. The column was developed with a 90-minute linear gradient of acetonitrile in 0.125% formic acid delivered at 280 nL/min. Tandem mass spectra were collected from duplicate samples in a data-dependent manner with an LTQ Orbitrap VELOS mass spectrometer using a top 20 method, a dynamic exclusion repeat count of 1 and a repeat duration of 35 s. MS/MS spectra were evaluated using SEQUEST 3G and the SORCERER 2 platform from Sage-N Research (v4.0, Milpitas CA) \[[@pone.0117966.ref035]\]. Searches were performed against the most recent update of the NCBI *Rattus norvegicus/Toxoplasma gondii* combined database with mass accuracy of +/-50 ppm for precursor ions and 1 Da for product ions. Results were filtered with mass accuracy of +/− 5 ppm on precursor ions and presence of an acetylated lysine. The mzXML, Dtas, and Out files associated with this study are available upon request. Label-free quantification of individual acetylation sites was performed as previously described, with the fold change for each identified acetylated lysine was calculated by comparing changes in parent peptide ion intensities between uninfected and infected samples \[[@pone.0117966.ref036],[@pone.0117966.ref037]\].

Data analysis and bioinformatics {#sec007}
--------------------------------

Acetylated proteins were classified according to gene ontology (GO) annotations by Uniprot (<http://www.uniprot.org>) \[[@pone.0117966.ref038]\]. Cellular localization data were also extracted from Uniprot. The secretome analysis was performed using Secretome 2.0 server (<http://www.cbs.dtu.dk/services/SecretomeP>) \[[@pone.0117966.ref039]\]. Amino acid sequence motifs were analyzed using WebLogo 3.4 (<http://weblogo.threeplusone.com/create.cgi>) \[[@pone.0117966.ref040]\].

Immunofluorescence assay {#sec008}
------------------------

Immunofluorescence assays were performed as previously described \[[@pone.0117966.ref041]\]. Briefly, astrocyte monolayers grown on coverslips were inoculated with RH strain tachyzoites. After removal of culture medium, infected HFFs were fixed in 4% paraformaldehyde for 10 min and then were permeabilized with 0.3% Triton X-100 for 10 min. For visualization of α-tubulin or α-tubulin acetylated at K40, mouse monoclonal anti-α-tubulin antibody (clone DM1A, Sigma T6199) and monoclonal anti-acetylated tubulin antibody (clone 6--11B-1, Sigma T7451) were applied at 1:2,000 followed by goat anti-mouse Alexa Fluor 488 secondary antibody at 1:2,000 (Invitrogen, A-11001). Nuclei were visualized through co-staining with 4′,6-diamidino-2-phenylindole (DAPI).

Ethics statement {#sec009}
----------------

Astrocytes were obtained from postnatal rat pups (DIV1--2) using an approved protocol (10354) from the Institutional Animal Care and Use Committee (IACUC) of the University of Indiana School of Medicine (IUSM). The IUSM is accredited by the International Association for Assessment and Accreditation of Laboratory Animal Care. Animals were anesthetized using volatile anesthetics (halothane/isofluorane) and euthanized by decapitation.

Results and Discussion {#sec010}
======================

Proteome-wide analysis of lysine acetylated proteins in cortical astrocytes {#sec011}
---------------------------------------------------------------------------

As the most abundant type of cell in the mammalian brain, astrocytes carry out a variety of essential functions that include supporting synapse formation, synaptic transmission, and responding to neuronal stress. Astrocytes have been linked to neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's, as well as amyotrophic lateral sclerosis \[[@pone.0117966.ref042],[@pone.0117966.ref043]\]. Efforts to better understand the functions of astrocytes have included recent analyses of the whole-cell proteome and secretome \[[@pone.0117966.ref044]--[@pone.0117966.ref049]\]. The most recent and comprehensive proteomics study to date was performed using C8-D1A, a type-1 murine astrocyte cell line \[[@pone.0117966.ref050]\]. Using this cell line, researchers identified 7,183 proteins in the whole-cell astrocyte proteome and 6,067 proteins in the secretome. To date, no one has examined the post-translational modifications (PTMs) that may be decorating the proteome in transformed or dissociated astrocytes.

It has now been established for a wide variety of model organisms that thousands of proteins are subject to lysine acetylation throughout cells; however, an acetylome has yet to be determined for any individual brain cell type to date. To address this knowledge gap, and to further examine whether lysine acetylation is altered in response to infection, we performed proteome-wide analyses of lysine acetylated proteins in cortical astrocytes obtained from rat using a strategy outlined in [Fig. 1](#pone.0117966.g001){ref-type="fig"}. The significance of charting the astrocyte proteome is underscored by previous studies suggesting that lysine deacetylase (KDAC) inhibitors, such as suberoylanilide hydroxamic acid and valproic acid, show promise in treating some of the aforementioned neurodegenerative diseases in which astrocytes may play a role \[[@pone.0117966.ref051]--[@pone.0117966.ref053]\]. We first describe the results of the uninfected astrocytes, with the infected astrocyte acetylome discussed in the following section.

![Workflow for acetylome analysis of cortical astrocytes.\
Protein lysates generated from infected and uninfected cortical astrocytes were subjected to proteolysis to generate a peptide suspension. Immunoaffinity purification with anti-acetyl-lysine antibody enriched for acetylated peptides (acetylation mark is denoted by red dot). Identification of acetylated peptides was achieved with mass spectrometry.](pone.0117966.g001){#pone.0117966.g001}

Cortical astrocytes were cultured from postnatal day 1--3 Sprague-Dawley rat pups. Generation of whole cell lysates, affinity enrichment of peptides containing acetylated lysine residues, and their identification by mass spectrometry were carried out essentially as described (\[[@pone.0117966.ref030]\]; see also [Materials and Methods](#sec002){ref-type="sec"}). Using this approach, we were able to detect lysine acetyl sites on 516 non-redundant peptides across 304 astrocyte proteins at a false discovery rate (FDR) for peptides of less than 5% ([S1 Table](#pone.0117966.s001){ref-type="supplementary-material"}). Highlighting the fidelity of our approach and source sample, three marker proteins that distinguish astrocytes from other neuronal cells were detected in our acetylome: fructose-bisphosphate aldolase C (lysine (K) acetylated at amino acid residue 147 (K147)), nuclear factor 1 A-type, NFI-A (K276) and glial fibrillary acidic protein (GFAP) (K258) \[[@pone.0117966.ref050],[@pone.0117966.ref054],[@pone.0117966.ref055]\].

For a global view of the acetylome, we categorized the acetylated astrocyte proteins into functional groups based on gene ontology ([S2 Table](#pone.0117966.s002){ref-type="supplementary-material"}). The majority of the acetylated sites and proteins cluster into groups including RNA processing/transcription, metabolism, chromatin biology, and translation ([Fig. 2A-B](#pone.0117966.g002){ref-type="fig"}). As expected, histone proteins are heavily acetylated ([S3 Table](#pone.0117966.s003){ref-type="supplementary-material"}). Acetylation and deacetylation of histones by histone acetyltransferases (HATs) or histone deacetylases (HDACs), respectively, are well-established PTMs that modulate gene expression \[[@pone.0117966.ref056],[@pone.0117966.ref057]\].

![Global features of the cortical astrocyte acetylome.\
Acetylated proteins (A) and residues (B) were sorted into functional groups based on GO analyses. Lysine acetylation is most prevalent on proteins involved in RNA processing and transcription, metabolism, and chromatin biology. C. The 277 novel acetyl-lysine sites identified in our study are present on proteins that encompass a wide range of cellular functions. D. Proteins detected as lysine-acetylated were grouped based on their respective cellular location.](pone.0117966.g002){#pone.0117966.g002}

The first proteomic survey of lysine acetylation was performed in HeLa cells and identified 388 lysine acetylation sites across 195 proteins, which largely clustered into functional categories involving transcription, translation, and metabolism \[[@pone.0117966.ref058]\], which is comparable to our astrocyte acetylome. A subsequent study performed on human liver identified 1,047 proteins containing lysine acetyl marks, preferentially on those involved in metabolism \[[@pone.0117966.ref029]\]. A cardiac acetyl-lysine proteome was determined in guinea pigs, revealing that \>60% of acetylated proteins are mitochondrial and mainly involved in metabolism, as well as apoptosis and transcription \[[@pone.0117966.ref059]\]. It is not surprising that different cell types would have variances in the type and abundance of lysine acetylated proteins, but a striking commonality that emerges from these collective acetylomes is the abundance of acetylation on metabolic proteins.

Of the 304 proteins we detected as being acetylated in astrocytes, 186 are novel, having never been previously reported as acetylated in *Rattus novergicus* in Uniprot \[[@pone.0117966.ref038]\]; thus, our data significantly expands the number of known acetylated lysine sites. The novel lysine acetylation marks we detected were found primarily on proteins associated with RNA processing and transcription, metabolism, chromatin biology, and translation ([Fig. 2C](#pone.0117966.g002){ref-type="fig"}).

We examined the presence of acetylated proteins in different subcellular compartments. Our data reveals that proteins subject to lysine acetylation in astrocytes are predominantly found in the nucleus (38.5%), followed by the cytoplasm (28%) and mitochondria (20%). Eleven of the acetylated proteins (3.6% of the acetylome) are secreted from astrocytes ([Fig. 2D](#pone.0117966.g002){ref-type="fig"}).

One of the secreted proteins which we identified as acetylated is a complement protein involved in innate immunity: C3, which is acetylated on K215 within the N-terminal beta chain region. Complement C3 has not previously been reported to be acetylated, so it is unclear what the function of this acetylation site may be. It is possible that acetylation of complement C3 could alter folding of the protein and affect secretion and/or cleavage of C3 by C3 convertase, thus regulating the downstream complement cascade. This is particularly intriguing considering our finding that this acetyl mark is increased 3.3-fold upon *T*. *gondii* infection (see below), lending support to the idea that acetylation of K215 on C3 may modulate complement function. Treatment with the lysine deacetylase (KDAC) inhibitors sodium butyrate and Trichostatin A has been shown to enhance complement C3 expression and secretion, through increased histone acetylation \[[@pone.0117966.ref060]\], but the direct action of KDACs on complement C3 itself was not considered.

Transmembrane glycoprotein NMB precursor (Gpnmb) was another secreted protein on which a novel acetylation site was identified, K170. Also known as osteoclavin in rats, this highly glycosylated protein is anchored in the plasma membrane and has been shown to regulate cellular differentiation, specifically the development of osteoblasts in bone \[[@pone.0117966.ref061]\]. Gpnmb was also found to be upregulated in both neurons and astrocytes after brain ischaemic injury in rats and overexpression of Gpnmb was protective against ischaemic injury \[[@pone.0117966.ref062]\], indicating a role for Gpnmb in neuroprotection. Acetylation of Gpnmb may be involved in the regulation of these neural repair processes, through controlling Gpnmb secretion or glycosylation.

As mentioned above, histone proteins are known to be heavily acetylated and this is no exception in astrocytes ([S3 Table](#pone.0117966.s003){ref-type="supplementary-material"}). Unexpectedly, we found novel histone acetylation sites on some astrocyte histones. For example, linker histone H1C is acetylated at K17, K75, and K84, in addition to the previously detected K46, K90, and K106 (<http://www.phosphosite.org/proteinAction.do?id=3849&showAllSites=true>) \[[@pone.0117966.ref063]\]. The most abundant acetylated non-histone protein in cultured cortical rat astrocytes is α-tubulin, which we detected as acetylated at K40. K40 acetylation is widespread among eukaryotes and its role in the cell remains a topic of intense investigation. Acetylated tubulin is a feature of long-lived, stable microtubules \[[@pone.0117966.ref064]\] and may interplay with additional PTMs to form a "tubulin code" that provides microtubules flexibility to execute a wide variety of cellular functions \[[@pone.0117966.ref065]\]. We performed immunofluorescent analysis using an antibody specific against the acetylated K40 residue of tubulin, which confirms that acetylated microtubules are abundant in cortical astrocytes and localized uniformly throughout the cell ([Fig. 3](#pone.0117966.g003){ref-type="fig"}).

![Localization of acetylated tubulin in astrocytes.\
The subcellular localization of α-tubulin acetylated at K40 (upper panels) and total α-tubulin (lower panels) through immunofluorescence of isolated cortical astrocytes (green). DAPI staining to highlight nuclei is indicated in blue. Scale bar = 20 μm.](pone.0117966.g003){#pone.0117966.g003}

A KEGG pathway analysis using DAVID (Database for Annotation, Visualization and Integrated Discovery; <http://david.abcc.ncifcrf.gov/home.jsp>) \[[@pone.0117966.ref066],[@pone.0117966.ref067]\] of the astrocyte acetylome clustered 123 of the 304 acetylated proteins as proteins linked to neurological disorders, such as Huntington's disease (18 proteins), Parkinson's disease (15 proteins), and Alzheimer's disease (12 proteins) ([Table 1](#pone.0117966.t001){ref-type="table"} and [S4 Table](#pone.0117966.s004){ref-type="supplementary-material"}). Acetylated proteins are also associated with canonical metabolic pathways that have been shown to be specifically enriched in astrocytes compared to neurons and oligodendrocytes \[[@pone.0117966.ref068]\], including the citrate cycle, fatty acid metabolism, and valine, leucine, and isoleucine degradation ([S4 Table](#pone.0117966.s004){ref-type="supplementary-material"}).

10.1371/journal.pone.0117966.t001

###### Proteins involved in neurological disorders that are acetylated in murine astrocytes.

![](pone.0117966.t001){#pone.0117966.t001g}

  Neurological disorder      Accession number   Protein name
  -------------------------- ------------------ --------------------------------------------------------------------------------------
  **Huntington's Disease**   Q9Z2L0             voltage-dependent anion-selective channel protein 1
                             P10719             ATP synthase subunit beta, mitochondrial precursor
                             P35434             ATP synthase subunit delta, mitochondrial precursor
                             B2RYS2             cytochrome b-c1 complex subunit 7
                             Q4QQW4             histone deacetylase 1
                             P81155             voltage-dependent anion-selective channel protein 2
                             P19511             ATP synthase subunit b, mitochondrial precursor
                             P29418             ATP synthase subunit epsilon, mitochondrial
                             P15999             ATP synthase subunit alpha, mitochondrial precursor
                             P31399             ATP synthase subunit d, mitochondrial
                             Q09073             ADP/ATP translocase 2
                             Q920L2             succinate dehydrogenase \[ubiquinone\] flavoprotein subunit, mitochondrial precursor
                             Q6JHU9             CREB-binding protein
                             Q05962             ADP/ATP translocase 1
                             Q5M9I5             cytochrome b-c1 complex subunit 6, mitochondrial
                             P07895             superoxide dismutase \[Mn\], mitochondrial precursor
                             Q9R1Z0             voltage-dependent anion-selective channel protein 3
                             Q06647             ATP synthase subunit O, mitochondrial precursor
  **Parkinson's Disease**    Q9Z2L0             voltage-dependent anion-selective channel protein 1
                             P10719             ATP synthase subunit beta, mitochondrial precursor
                             P35434             ATP synthase subunit delta, mitochondrial precursor
                             B2RYS2             cytochrome b-c1 complex subunit 7
                             P81155             voltage-dependent anion-selective channel protein 2
                             P19511             ATP synthase subunit b, mitochondrial precursor
                             P29418             ATP synthase subunit epsilon, mitochondrial
                             P15999             ATP synthase subunit alpha, mitochondrial precursor
                             P31399             ATP synthase subunit d, mitochondrial
                             Q09073             ADP/ATP translocase 2
                             Q920L2             succinate dehydrogenase \[ubiquinone\] flavoprotein subunit, mitochondrial precursor
                             Q05962             ADP/ATP translocase 1
                             Q5M9I5             cytochrome b-c1 complex subunit 6, mitochondrial
                             Q9R1Z0             voltage-dependent anion-selective channel protein 3
                             Q06647             ATP synthase subunit O, mitochondrial precursor
  **Alzheimer's Disease**    P19511             ATP synthase subunit b, mitochondrial precursor
                             P15999             ATP synthase subunit alpha, mitochondrial precursor
                             P29418             ATP synthase subunit epsilon, mitochondrial
                             P31399             ATP synthase subunit d, mitochondrial
                             P10719             ATP synthase subunit beta, mitochondrial precursor
                             P35434             ATP synthase subunit delta, mitochondrial precursor
                             P62161             calmodulin
                             B2RYS2             cytochrome b-c1 complex subunit 7
                             Q920L2             succinate dehydrogenase \[ubiquinone\] flavoprotein subunit, mitochondrial precursor
                             P04797             glyceraldehyde-3-phosphate dehydrogenase
                             Q5M9I5             cytochrome b-c1 complex subunit 6, mitochondrial
                             Q06647             ATP synthase subunit O, mitochondrial precursor

We also assessed if the amino acids flanking the targeted acetyl-lysine exhibits bias towards a certain motif and if there is significant enrichment or absence of specific amino acids with respect to the general amino acid composition of the entire *Rattus norvegicus* proteome. For these analyses, we generated WebLogo sequence motifs \[[@pone.0117966.ref040]\] and IceLogo heat maps \[[@pone.0117966.ref069]\]. As previously reported for multiple cell types, we found that lysine acetylation of astrocyte proteins also generally occurs in lysine-rich regions, with a significant enrichment for glycine and alanine at positions-1, -2, and-3 and positions +1, +2, and +5 for alanine only, as shown in [Fig. 4A](#pone.0117966.g004){ref-type="fig"} \[[@pone.0117966.ref027],[@pone.0117966.ref028]\]. The heat map also shows an absence of serine, proline, and histidine at position +1, and a general lack of leucine in the vicinity of the acetylation site. However, the preponderance of histone proteins in acetylome datasets likely biases the global motif analysis; searching for only the acetylated proteins in mitochondria reveals a striking deviance from other acetylation sites ([Fig. 4B](#pone.0117966.g004){ref-type="fig"}). In the acetylated proteins in astrocyte mitochondria, there is a modest enrichment for glutamate (E) at the-1 position, which has been observed before in multiple studies \[[@pone.0117966.ref070]\]. Analysis of the histone proteins alone revealed a high conservation of the GK motif, with additional lysines at the + and---4 positions, consistent with acetylated histones in other species and cell types \[[@pone.0117966.ref028],[@pone.0117966.ref058]\]. Our data lends support to the idea that different motifs are targeted by distinct KATs residing in that particular cellular compartment \[[@pone.0117966.ref070]\].

![Analysis of acetylated lysine sites.\
A. Heat map of amino acid composition of acetylation sites in *Rattus norvegicus* astrocytes, displaying amino acids that are significantly enriched (green) or absent (red) relative to the general amino acid composition of the *Rattus norvegicus* proteome. B. Sequence motifs of astrocyte acetylation sites +/-7 amino acids from the targeted lysine residue. Motifs were compiled using all acetylated peptides or only those found in histones, non-histone proteins, or mitochondrial proteins.](pone.0117966.g004){#pone.0117966.g004}

Differences in lysine acetylation in astrocytes infected with *T*. *gondii* {#sec012}
---------------------------------------------------------------------------

The results above establish that many other proteins in addition to histones are subject to lysine acetylated in astrocytes. We also addressed how the acetylome in cortical astrocytes is impacted by *T*. *gondii* infection. In parallel studies, we performed an acetylome on astrocytes that were infected with RH strain *T*. *gondii* tachyzoites for 10 hours, at which point vacuoles contain 2--4 parasites. Compared to the uninfected astrocytes, 58 proteins were differentially acetylated when infected with *T*. *gondii*. [Table 2](#pone.0117966.t002){ref-type="table"} lists the 34 proteins that exhibit at least a 2-fold increase in lysine acetylation; 9 of these proteins contain 10 novel acetylated lysines that have yet to be reported.

10.1371/journal.pone.0117966.t002

###### Proteins showing ≥2-fold increase in lysine acetylation in *T. gondii*-infected astrocytes.

![](pone.0117966.t002){#pone.0117966.t002g}

  Functional Group                                       Accession number                                          Protein name                                               Normalized Fold-change
  ------------------------------------------------------ --------------------------------------------------------- ---------------------------------------------------------- ------------------------
  **Chromatin Biology**                                  P62804                                                    histone H4                                                 2.2
  XP_001054684                                           histone H4 replacement-like                               2.4                                                        
  P84245                                                 histone H3.3B-like                                        4.4                                                        
  P0C0S7                                                 histone H2A.Z                                             11.5                                                       
  Q6LED0                                                 histone H3.3                                              665.7                                                      
  **Differentiation**                                    F1LRS2                                                    dedicator of cytokinesis 7                                 3.3
  **Immunity**                                           P01026                                                    complement C3                                              3.3
  **Metabolism**                                         P97519                                                    hydroxymethylglutaryl-CoA lyase, mitochondrial precursor   2.1
  P04636                                                 malate dehydrogenase, mitochondrial precursor             2.1                                                        
  P17764                                                 acetyl-CoA acetyltransferase, mitochondrial precursor     2.1                                                        
  P12785                                                 fatty acid synthase                                       2.3                                                        
  P29411                                                 GTP:AMP phosphotransferase, mitochondrial                 2.4                                                        
  Q811I0                                                 ATP synthase mitochondrial F1 complex assembly factor 1   3.4                                                        
  P15999                                                 ATP synthase subunit alpha, mitochondrial precursor       4.2                                                        
  **Miscellaneous**                                      P07895                                                    superoxide dismutase \[Mn\], mitochondrial precursor       2.1
  P48679                                                 prelamin-A/C isoform C2                                   2.7                                                        
  P07895                                                 superoxide dismutase \[Mn\], mitochondrial precursor      5.4                                                        
  Q6P7C7                                                 transmembrane glycoprotein NMB precursor                  136                                                        
  **RNA processing & transcription**                     B0BNB4                                                    mediator of RNA polymerase II transcription subunit 6      2.2
  Q66H19                                                 serum response factor-binding protein 1                   2.2                                                        
  Q6IMY8                                                 heterogeneous nuclear ribonucleoprotein U                 3                                                          
  P09416                                                 myc proto-oncogene protein (c-Myc)                        3                                                          
  P0C1G9                                                 transcription factor SOX-11                               3.5                                                        
  Q5TKR9                                                 histone acetyltransferase MYST3                           5.2                                                        
  Q6JHU9                                                 CREB-binding protein (CBP)                                6.6                                                        
  Q99MK2                                                 histone acetyltransferase KAT5/TIP60                      6.9                                                        
  **Stress response, chaperones, protein degradation**   P26772                                                    10 kDa heat shock protein, mitochondrial                   2
  P14659                                                 heat shock-related 70 kDa protein 2                       2.3                                                        
  **Translation & ribosomal proteins**                   Q3T1J1                                                    eukaryotic translation initiation factor 5A-1              2.8
  P18445                                                 60S ribosomal protein L27a                                4.5                                                        
  **Transport**                                          Q75Q39                                                    mitochondrial import receptor subunit TOM70                2.1
  P61972                                                 nuclear transport factor 2                                2.9                                                        
  P02770                                                 serum albumin precursor                                   6.3                                                        
  **Unknown**                                            Q5RKH0                                                    putative oxidoreductase GLYR1                              2

Notably, several of the acetylated proteins in the infected astrocytes are transcription factors and KATs themselves, which may be involved with the profound changes in gene expression programs previously observed in other *T*. *gondii*-infected cells. Consistent with the up-regulation of host cell genes upon *T*. *gondii* invasion, hyperacetylation of canonical histones is observed, particularly on H3.3, which shows a remarkable 600-fold increase in lysine acetylation ([Table 2](#pone.0117966.t002){ref-type="table"}). Such a large effect on histone acetylation suggests that modulations in host cell gene expression are largely driven at the epigenetic level.

The greatest increase in acetylation in response to *T*. *gondii* infection on a non-histone protein occurs on K170 of GPNMB/osteoactivin, a type I transmembrane glycoprotein nonmetastatic melanoma B (136-fold increase, [Table 2](#pone.0117966.t002){ref-type="table"}). GPNMB plays multiple roles, including bone regeneration, tumor growth regulation, and T-cell inactivation \[[@pone.0117966.ref071]--[@pone.0117966.ref073]\]. In astrocytes, GPNMB is secreted as a neuroprotective factor \[[@pone.0117966.ref062],[@pone.0117966.ref074]\]. As GPNMB is also important for tissue repair \[[@pone.0117966.ref075]\], this protein may help manage the damage done by the parasite. The role of acetylation on GPNMB is unknown, and there has been no previous link between this protein and *T*. *gondii* infection.

Increased acetylation in select proteins during infection may be due in part to acetylation of KATs like CBP and TIP60 themselves, which display a 6.6- and 6.9-fold increase, respectively ([Table 2](#pone.0117966.t002){ref-type="table"}). K327 acetylation, for example, has been linked to maximizing TIP60 enzyme activity \[[@pone.0117966.ref076]\]. TIP60 has also been shown to interact with and acetylate c-Myc, dramatically enhancing the stability of c-Myc protein \[[@pone.0117966.ref077]\]. It is tempting to speculate that *T*. *gondii* infection modulates these KAT enzymes, which then leads to hyperacetylation of their corresponding substrates.

Two dozen astrocyte proteins exhibited 2-fold less acetylated lysine levels in the acetylome from *T*. *gondii*-infected astrocytes ([Table 3](#pone.0117966.t003){ref-type="table"}), and 28 of the acetylated lysines across these 24 proteins have never been reported in Uniprot. Nearly 30% of the decreased acetylation appears on variant histones, suggesting that *T*. *gondii* infection of astrocytes is a large driver of changes in host gene expression. Previous studies have shown that *T*. *gondii* infection results in decreased acetylation of core histones H3 and H4 located at the promoters of IFNγ-regulated genes \[[@pone.0117966.ref078]\]. However, no studies have examined the roles of histone variants in host cells infected with *T*. *gondii*. Our results suggest that the rewiring of host cell gene expression in response to infection is highly sophisticated and may involve an opposing interplay of acetylation on canonical versus variant histones.

10.1371/journal.pone.0117966.t003

###### Proteins showing ≤2-fold decrease in lysine acetylation in *T. gondii*-infected astrocytes.

![](pone.0117966.t003){#pone.0117966.t003g}

  Functional group                                       Accession number                                             Protein name                                     Normalized Fold-change
  ------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------------ ------------------------
  **Cell cycle**                                         B2RYQ5                                                       enhancer of rudimentary homolog                  -2.3
  **Chromatin Biology**                                  D3ZWM5                                                       histone cluster 1, H2bd-like                     -2.6
  Q9Z2Q9                                                 histone H2B                                                  -2.6                                             
  Q63945                                                 protein SET                                                  -2.7                                             
  D3ZLY9                                                 histone cluster 1, H2bp                                      -3.1                                             
  G3V8B3                                                 histone cluster 1, H2bm                                      -3.5                                             
  P62804                                                 histone cluster 1, H4m                                       -3.7                                             
  M0RCB8                                                 histone H3.3B-like                                           -6                                               
  D3ZNZ9                                                 histone cluster 3, H2ba                                      -10.1                                            
  **Cytoskeleton**                                       P68370                                                       tubulin alpha-1A chain                           -2.3
  **Differentiation**                                    P62161                                                       calmodulin                                       -2.4
  **Metabolism**                                         Q9EQS0                                                       transaldolase                                    -2.3
  P16617                                                 phosphoglycerate kinase 1                                    -3                                               
  P56574                                                 isocitrate dehydrogenase \[NADP\], mitochondrial precursor   -10.2                                            
  **Miscellaneous**                                      P10111                                                       peptidyl-prolyl cis-trans isomerase A            -2.2
  **RNA processing & transcription**                     A7VJC4                                                       heterogeneous nuclear ribonucleoproteins A2/B1   -2
  B0BNB4                                                 chromatin modification-related protein MEAF6                 -2.1                                             
  Q4V898                                                 heterogeneous nuclear ribonucleoprotein G                    -2.3                                             
  A1L130                                                 inhibitor of growth protein 4                                -2.4                                             
  D4A411                                                 peregrin                                                     -11.3                                            
  **Stress response, chaperones, protein degradation**   Q91XW0                                                       heat shock protein HSP90-alpha                   -19.2
  **Translation & ribosomal proteins**                   Q68FR6                                                       elongation factor 1-gamma                        -2.2
  **Transport**                                          P02693                                                       fatty acid-binding protein, intestinal           -2.1
  Q05962                                                 ADP/ATP translocase 1                                        -7                                               

The most dramatic reduction of lysine acetylation was observed for K408 of the heat shock protein Hsp90α, exhibiting a 19.2-fold decrease in the acetylome of infected astrocytes ([Table 3](#pone.0117966.t003){ref-type="table"}). Hsp90α is an essential molecular chaperone that activates multiple client proteins typically in response to cellular stress \[[@pone.0117966.ref079]\]. Activation of Hsp90α and interactions with its client proteins and co-chaperones are mediated by several PTMs including lysine acetylation \[[@pone.0117966.ref080]\]. The acetylation of K408 has not been reported to date, but it was detected as ubiquitylated in mice and humans \[[@pone.0117966.ref081],[@pone.0117966.ref082]\], making it possible that acetylation here prevents Hsp90α degradation. The dramatic reduction in deacetylation of K408 suggests that Hsp90α may be suppressed in response to *T*. *gondii* infection.

Another protein with greatly reduced acetylation (\<10-fold) in the infected astrocyte acetylome is isocitrate dehydrogenase (IDH2), at K180. As a supplier of NADPH, IDH2 is a critical component of the mitochondrial antioxidant pathway \[[@pone.0117966.ref083]\], and is necessary for the regeneration of reduced glutathione (GSH), the major antioxidant responsible for preventing ROS damage \[[@pone.0117966.ref084]\]. IDH2 acetylation at K143 results in a 44-fold loss in activity; deacetylation by SIRT3 restores IDH2 activity and protects cells from oxidative stress \[[@pone.0117966.ref085]\]. It is possible that *T*. *gondii* mediates a deacetylation of IDH2 to protect its host cell from oxidative or other stresses associated with managing infection, but further studies are required to determine the role this lysine plays in IDH2 function in both infected and uninfected astrocytes.

Conclusions {#sec013}
===========

Recent studies have implicated important roles for lysine acetylation in other cell types during viral infection that involve interference with host cell KATs \[[@pone.0117966.ref086]\], hijacking of host cell acetylome machinery or acetylation of viral proteins \[[@pone.0117966.ref087]--[@pone.0117966.ref091]\], and other changes in lysine acetylation during infection or in response to viral pathogens \[[@pone.0117966.ref092],[@pone.0117966.ref093]\]. Intracellular bacteria also effect host cell lysine acetylation. For example, *Salmonella enterica* appear to exploit the host TIP60 KAT activity to promote efficient replication inside host cells \[[@pone.0117966.ref094]\]. Additionally, *Salmonella typhimurium* infection increases p53 acetylation in intestinal epithelial cells \[[@pone.0117966.ref095]\]. Our study lends support to the idea that intracellular pathogens modulate host cell proteomes and PTMs such as lysine acetylation. Previously, it has also been shown that host cell proteins can be differentially phosphorylated in response to *T*. *gondii* infection \[[@pone.0117966.ref019]\].

It is important to note that some of the changes in acetylation detected in the infected astrocytes could potentially be reflective of changes in the abundance of that protein induced by the infection. Future studies are required to elucidate the biological consequences of the changes we detected in the astrocyte acetylome upon infection with *T*. *gondii*, as alterations in lysine acetylation status could affect protein localization, function, stability, or interactions \[[@pone.0117966.ref096]\].

*T*. *gondii* secretes numerous proteins that alter host cell protein phosphorylation \[[@pone.0117966.ref097]--[@pone.0117966.ref099]\]. *T*. *gondii* possesses several KATs and KDACs, but there is no evidence that these are secreted. A more likely mechanism is that *T*. *gondii* effector proteins modulate host KATs and KDACs activities that lead to altered acetylation patterns. Our datasets provide a wealth of new information, including 186 novel lysine acetylation sites to add to the cellular inventory of PTMs. These data serve as valuable resources to generate hypotheses about astrocyte physiology and to interrogate how the changes in host cell lysine acetylation may contribute to the effectiveness of *T*. *gondii* infection.
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